There was slightly increased immunoreactivity of MMP9 observed in the co-existing invasive BC cells (Fig. 1c), in the intravascular tumour cell emboli (Fig. 1d), stromal expression (Fig. 1e) and Fig. 1f showing No Primary Antibody Control. Here, MMP9 is linked to breast cancer.